Areas of Research Sickle Cell Disease and Thalassemia
The Sickle Cell and Thalassemia Program conducts leading-edge clinical and laboratory research to advance understanding of these disorders, prevent complications, and develop more effective treatments with the ultimate goal of finding a cure. Through the integration of scientific discovery and patient care, physician-scientists at Texas Children’s Cancer and Hematology Center are helping shape the future of sickle cell disease and thalassemia treatment.
Children receiving care through the Sickle Cell and Thalassemia Program may have access to NIH-funded and industry-sponsored clinical studies led by our experts, providing opportunities to receive promising new therapies while contributing to advances in care. These research efforts are supported through government grants and the philanthropic contributions of community-based organizations, helping expand access to innovative treatment options for our patients.
